FDA Advisory Panel Vote Inconclusive on Whether Vertex's Lumacaftor Contributes Positively to Orkambi's Effectiveness By: Benzinga via Benzinga May 12, 2015 at 15:30 PM EDT -DJ Read More >> Related Stocks: Vertex Pharmaceuticals